Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 3Sbio, Amarin, Ampio, Astrazeneca, Beigene, Bellerophon, Biolinerx, Biontech, Bioshin, Boehringer Ingelheim, CASI, Clear Creek, Cytodyn, Edding, Eisai, Gannex, Gemvax & Kael, Helixmith, Idorsia, Immutep, Imugene, Innovent, Kangpu, Kazia, Marinomed, Merck, Molecular Partners, Mydecine Innovations, Organicell Regenerative Medicine, Pfizer, Redhill, Sagimet, Selecta, Trippbio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Asieris, Astrazeneca, Bioaegis, Biological E., Corvus, Curevac, Cynata, Dynavax, Glaxosmithkline, Immunitybio, Medicago, Merck, Mesoblast, Moderna, Neurorx, Organicell, PTC, RDIF, Redhill, Relief, Revelation, Reven, Sagent, Selva, Shanghai Henlius, Takeda, UVA.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Agenus, Arch, Arcturus, Celltrion, Daewoong, Eisai, Humanigen, Immunitybio, Inmune, Israel Institute for Biological Research, Neurorx, Novartis, Pfizer, Relief, Sheba Medical Center.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aerpio, Agenus, Algernon, Ampio, Anheart, Astrazeneca, Aurinia, Biogen, Biontech, Boehringer Ingelheim, Cerecin, Clinuvel, Connect, Curevac, Daiichi Sankyo, Eisai, Eli Lilly, Equillium, Gilead Sciences, Humanigen, Immunic, Kintor, Moderna, Novavax, Olatec, Pfizer, Regeneron, Revimmune, Russian Direct Investment Fund, Spark Global, Sun, Symvivo, Takeda, Tetra, Therapeutics Solution International, Tiziana Life Sciences, União Química Farmacêutica Nacional.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abpro, Ana, Appili, Ardelyx, Aslan, Atyr, Biophytis, Biosig Technologies, Cytodyn, Daiichi Sankyo, Enlivex, Gmax, Hifibio, Immunitybio, Immutep, Kyowa Kirin, Mesoblast, Moderna, Nantkwest, Neuclone, Ono, Phasebio, Rafael, Reistone, Trippbio, Viralclear.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abbvie, Apellis, Apogenix, Arch Biopartners, Boehringer Ingelheim, Eiger, Faron, GNT Pharma, Humanigen, Ionis, Johnson & Johnson, Merck, Mesoblast, Nasus Pharma, Neurorx, Pharmamar, Relief, Shionogi, Taiwan Liposome, Vaxart.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Caladrius, Celltrion, Chromadex, CSL Behring, Eli Lilly, Emergent Biosolutions, Gilead Sciences, Glaxosmithkline, Grifols, Napajen, Noxopharm, Redhill Biopharma, Rigel, Seagen, Takeda, University of Oxford, Vir, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Astrazeneca, Corvus, Curevac, Eisai, Enlivex, FSD, Harbour Biomed, Johnson & Johnson, Kancera, Kyowa Kirin, Medincell, Mei, Moderna, Regeneron, Revelation, Revive, Shanghai Junshi, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Apeiron, Bridge, Cipla, Covaxx, Dr. Reddy’s, Durect, Eiger, Enterome, Immunic, Innovent, Johnson & Johnson, Novavax, Oncimmune, Pulmatrix, Sinovac, Takeda, Viralclear.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 3D Medicines, Aim Immunotech, Algernon, Alphamab Oncology, Aslan, Astellas, Astrazeneca, Atossa, Atyr, Beigene, Clinuvel, Direct Biologics, Eli Lilly, Galera, Kyorin, Leap, Onconova, Opko Health, Rigel, Roche, Tracon.